Lanzamiento Enero 2027

Revisión sistemática2020Financiación no declarada

The Effects of Intermittent Fasting on Glycemic Control and Body Composition in Adults with Obesity and Type 2 Diabetes: A Systematic Review

Vitale R, Kim Y

Metabolic syndrome and related disorders · 31 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Revisión sistemática (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2020-08-11 · Metab Syndr Relat Disord · vol. 18 · número 10 · págs. 450–461
Editorial
Mary Ann Liebert, Inc.
Citado
43 citas · más que el 79% de estudios similares · 1.3× el promedio de su campo
Referencias
60 trabajos
Acceso
De pago
Áreas de investigación
Dietary Effects on Health · Diet and metabolism studies · Diabetes Management and Research
Palabras clave
intermittent fasting, glycemic control, body composition, obesity, type 2 diabetes, HbA1c, weight loss, caloric restriction, long-term follow-up
MeSH
humans, diabetes mellitus, type 2, obesity, weight loss, blood glucose, treatment outcome, caloric restriction, fasting, body composition, time factors, female, male, randomized controlled trials as topic, biomarkers, glycemic control, glycated hemoglobin

2 autores

  • Rosemarie Vitale🇺🇸 · autor de correspondenciaCentral Michigan University
  • Yeon Soo Kim🇺🇸Central Michigan University

Resumen

El texto original del estudio, en el idioma en que se publicó.

The purpose of this study was to evaluate the effects of intermittent fasting on glycemic control and body composition in adults with obesity and type 2 diabetes. Although intermittent fasting has shown some promise in improving glucoregulatory indicators and body composition in adults with obesity, there is currently no systematic review evaluating these effects in adults with obesity and type 2 diabetes. A database search of PubMed, CINHAL, and MEDLINE identified five studies that met inclusion criterion. All studies were randomized controlled trials in adult subjects (n = 46-137) with type 2 diabetes and a body mass index of ≥30 kg/m2. Four different intermittent fasting regimens were reviewed. All fasting regimens revealed strong evidence to support intermittent fasting as a feasible diet to improve glycemia and body composition measures within 12-24 weeks. Follow-up 12-18 months after intermittent fasting did not show promising results for continued weight loss and improved glycemic control. The majority of the studies demonstrated insignificant differences between intermittent fasting and continuous energy restriction for measures of glycated hemoglobin a1c and body composition. More data on intermittent fasting in adults with obesity and type 2 diabetes are needed to determine its benefits within this patient population. Future research should include consistent fasting regimens and larger sample sizes to improve the reliability and generalizability of the data. Also, consistent follow-up after a fasting intervention may enhance long-term benefits and should be considered in future research.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.